News Releases

Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
Hope for Eradicating Dormant but Deadly Cancer Cells
Women in Research: New Philanthropic Support for Early- and Mid-Career Female Faculty

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Robert W. Marion

Robert W. Marion, M.D.

Area(s) of expertise: Genetic diseasesAutismSudden infant death syndrome (SIDS) and Cardiogenetics

Dr. Marion is an internationally recognized pediatric geneticist who specializes in diagnosing and treating children with autism spectrum disorders and genetic diseases. His work with the Aguirre brothers, twins who were joined at the head… Learn more

Einstein in the News


NPR
Less Snacking, More Satisfaction: Some Foods Boost Levels of an Ozempic-Like Hormone

Gary Schwartz, Ph.D., describes how GLP-1, a hormone that is released during digestion, acts to stimulate insulin and slow how quickly food moves through the stomach into the intestine. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.

More coverage on Dr. Schwartz

MedPageToday
Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change

Sriram Machineni, M.B.B.S., comments on the results of a study he co-authored on the effectiveness of a phase III trial for tirzepatide, a weight loss drug, which helped study participants lose a significant amount of weight following a diet and exercise program. Dr. Machineni is associate professor of medicine and director of the Fleischer Institute Medical Weight Center at Einstein and Montefiore.

Additional coverage includes Medscape

US News & World Report
Black Patients 42% More Likely to Die After High-Risk Surgery Than White Patients

Tracey Straker, M.D., comments on a study that found high-risk surgeries are more deadly for Black and Hispanic Americans than their white counterparts, noting that social determinants of health, such as lack of insurance, play a role in the disparities. Dr. Straker is professor and chief of anesthesiology at Einstein and Montefiore.

More coverage on Dr. Straker

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos